Insulin R 1unit/mL Ophthalmic Solution
- Quantity: 8mL
- Price: $125 + Next Day Shipping. Login to the Practitioner Portal for all ophthalmic compounds pricing.
- Sig: Place 1 drop in affected eye(s) four times daily or as directed
Sterile compounded ophthalmic preparation available by prescription. The FDA does not review any compounded medication for safety or efficacy.
Topical insulin is being investigated for its potential role in corneal epithelial healing. Long-term ocular safety data remain limited, and patients should be monitored by their prescribing ophthalmologist throughout treatment.
Insulin Eye Drops for Corneal Re-Epithelialization and Neurotrophic Conditions
Topical insulin eye drops are being investigated as an adjunctive treatment for corneal epithelial healing, including persistent epithelial defects and neurotrophic corneal conditions. Clinical studies have reported encouraging results for epithelial healing, while evidence regarding corneal nerve regeneration remains more limited.
At Massey Drugs, we compound sterile insulin eye drops for ophthalmologists managing difficult-to-heal corneas where standard therapies alone may be insufficient. Insulin ophthalmic solutions are not commercially available and must be prepared by a compounding pharmacy with sterile ophthalmic capabilities. We work directly with eye care specialists and ship to patients in licensed states with rapid turnaround.
What Is Insulin Ophthalmic Solution?
Insulin is a peptide hormone best known for regulating blood glucose. When formulated as a topical ophthalmic solution, insulin is being studied for its potential to promote corneal epithelial repair.
Published clinical studies have investigated topical insulin in patients with persistent corneal epithelial defects and other ocular surface conditions. Although findings are promising, additional research is needed to establish optimal dosing, long-term safety, and effectiveness across different patient populations.
Mechanism of Action on the Cornea
Insulin is involved in cellular growth and repair signaling. Laboratory and early clinical research suggest that topical insulin may influence corneal healing through several proposed mechanisms:
Promoting corneal epithelial cell proliferation and migration
Supporting re-epithelialization of the corneal surface
Influencing cellular signaling pathways involved in tissue repair
Potentially supporting corneal nerve recovery, although clinical evidence remains limited
These proposed mechanisms have generated clinical interest in topical insulin for difficult-to-heal corneal epithelial defects. Its use should be determined by the treating ophthalmologist based on the underlying condition and available evidence.
Clinical Scenarios Where Ophthalmologists Explore Topical Insulin Eye Drops
Published clinical studies and case reports have investigated topical insulin eye drops in patients with compromised corneal epithelial healing, including:
Persistent corneal epithelial defects
Neurotrophic keratopathy
Dry eye disease associated with epithelial breakdown
Post-surgical or post-traumatic corneal epithelial defects
Topical insulin is an investigational, off-label treatment approach that ophthalmologists may consider in selected patients with difficult-to-heal corneal conditions. It is not an established first-line therapy.
Is Insulin Ophthalmic Solution a Standard Treatment?
No. There is currently no FDA-approved insulin ophthalmic product. Topical insulin has been investigated in clinical studies and published case reports involving corneal epithelial healing, but additional research is needed to establish its optimal use and long-term safety.
Massey Drugs prepares insulin ophthalmic solution as a patient-specific compounded medication. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before marketing.
Patient Instructions for Use
Massey Drugs provides written patient instructions with insulin ophthalmic solution, covering proper eye drop administration, storage requirements, and prescribed dosing frequency. These instructions help patients understand how to use and handle their medication throughout treatment.
Why Ophthalmologists Choose Massey Drugs
- Experienced sterile compounding laboratory for ophthalmic preparations
- Direct pharmacist access for formulation and clinical questions
- Familiarity with corneal and neurotrophic conditions
- Required next-day shipping for insulin ophthalmic solution
- Sterile compounding procedures and quality controls
- NAPB Accredited Compounding Pharmacy
States We Serve
Massey Drugs is licensed to dispense and ship prescription compounded medications to patients in 16 states: Alabama, Mississippi, Tennessee, Texas, Louisiana, Florida, Georgia, Kentucky, Indiana, Illinois, Ohio, Pennsylvania, New York, Connecticut, North Carolina, and South Carolina.
Ophthalmologists and other licensed prescribers in these states can work directly with Massey Drugs to prescribe patient-specific compounded ophthalmic medications, including Insulin Eye Drops.
How to Prescribe Insulin Eye Drops
Download a Prescription Form from the Practitioner Portal and send to Massey Drugs:
FAX: 800.637.2601
Phone: 833.540.3500
OR
e-Scribe: NPI#: 1295756245 | NCPDP#: 0127553
Massey Drugs | Cloverdale Road
Upon receipt of prescription, Massey Drugs contacts the patient to confirm shipping address and credit card payment.
Medication typically ships within 24–48 hours after patient address confirmation and payment, using required UPS Next Day shipping.
Massey Drugs provides competitively priced compounded ophthalmic eye drops with transparent, prescriber-accessible pricing.
All compound pricing can be viewed in our Practitioner Portal so costs can be communicated to patients before prescribing.
Speak with a Pharmacist
If you have questions about insulin ophthalmic compounding, dosing considerations, or appropriate clinical use, our pharmacists are available to consult.
Call 833-540-3500 to speak directly with a pharmacist.
Frequently Asked Questions
Can insulin eye drops be used alongside other dry eye or corneal therapies?
Topical insulin eye drops have been investigated as an adjunctive treatment alongside conventional ocular surface therapies, including lubricating drops, bandage contact lenses, and other treatments selected by the ophthalmologist. The combination of therapies depends on the underlying corneal condition, epithelial healing status, and individual patient needs.
How long does it typically take to see improvement with insulin ophthalmic solution?
Clinical response varies depending on the severity of the epithelial defect or neurotrophic condition being treated. Some patients may demonstrate improvement in epithelial healing or corneal sensitivity within several weeks, while others may require longer treatment durations and close ophthalmic monitoring.
Do insulin eye drops affect blood sugar levels?
Topical ophthalmic insulin is used at very low concentrations and is applied locally to the ocular surface. Systemic absorption is expected to be minimal, and clinically meaningful effects on blood glucose are not typically anticipated. However, prescribers may consider monitoring in patients with brittle diabetes or other metabolic concerns.
What happens if a patient misses a dose of insulin eye drops?
If a dose is missed, patients are generally advised to administer the next scheduled dose as directed rather than doubling up. Consistent dosing is important to support epithelial healing, so reinforcing adherence and proper instillation technique can help optimize treatment outcomes.
Can insulin ophthalmic solution be used long term?
Duration of therapy is determined by the treating ophthalmologist based on corneal healing progress and overall ocular surface stability. Some patients may use insulin eye drops for a defined healing period, while others with chronic neurotrophic or epithelial disorders may require extended treatment with periodic reassessment.
What are compounded insulin eye drops used for?
Topical insulin eye drops are being investigated for their potential role in corneal epithelial healing, particularly in patients with persistent corneal epithelial defects and neurotrophic keratopathy. They are not an FDA-approved ophthalmic treatment, and their use should be determined by the prescribing ophthalmologist based on the patient’s condition and available clinical evidence.
How much do insulin eye drops cost at Massey Drugs?
Massey Drugs compounds Insulin R 1 unit/mL Ophthalmic Solution in an 8 mL bottle for $125, plus $30 for required next-day shipping. A prescription is required. Ophthalmologists can submit prescriptions electronically or through the Massey Drugs Practitioner Portal. For assistance, call 833.540.3500.
Resources
- Topical insulin for ocular surface disease: A review
Journal of Ocular Pharmacology and Therapeutics, 2024. (PubMed) - Persistent Corneal Epithelial Defects: An overview of evaluation, current management and emerging therapies
Review of Ophthalmology (cornea/ocular surface review) — overview article published Oct 10, 2025. - Topical insulin eye drops show promise for treating ocular surface diseases
Ophthalmology360 — Ocular Surface Disease section (clinical/practice summary)
Additional Ophthalmic Compounding Capabilities
We compound additional sterile ophthalmic therapies used for:
- Post-operative Care
- Emergency & Infection Management
- Emergency & Corneal Scarring Support
- Glaucoma Compounding
- Myopia Management
Explore our full range of ophthalmic compounding capabilities.